Cargando…

Biotechnological Drugs: The Breakthrough in Autoimmune Rheumatic Conditions

Detalles Bibliográficos
Autores principales:	Cavagna, Lorenzo, Saketkoo, Lesley-Ann, Schwarting, Andreas, Caporali, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142382/ https://www.ncbi.nlm.nih.gov/pubmed/25180183 http://dx.doi.org/10.1155/2014/481973

Ejemplares similares

Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future
por: Mandel, Anna, et al.
Publicado: (2022)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Complex genetic association of 6q23 with autoimmune rheumatic conditions
por: Maxwell, James R, et al.
Publicado: (2009)

The Emerging Role of Biotechnological Drugs in the Treatment of Gout
por: Cavagna, L., et al.
Publicado: (2014)

POOR ADHERENCE TO DRUG TREATMENT IN CHILDREN AND ADOLESCENTS WITH AUTOIMMUNE RHEUMATIC DISEASES
por: Silva, Clovis Artur
Publicado: (2019)

Interstitial pneumonia with autoimmune features: a new classification still on the move
por: Cavagna, Lorenzo, et al.
Publicado: (2018)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases
por: Nakken, Britt, et al.
Publicado: (2012)

Biotechnology landscape in cancer drug discovery
por: Neagu, Monica, et al.
Publicado: (2015)

Vaccination of patients with autoimmune inflammatory rheumatic disease: physicians’ perspectives
por: Moon, Ki Won
Publicado: (2023)

Microbial Biotechnology‐2020
por: Timmis, Kenneth, et al.
Publicado: (2016)

Breakthrough Articles: Putting science first
por: Corey, David R., et al.
Publicado: (2014)

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
por: Suresh, Lakshmanan
Publicado: (2021)

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Natural Peptides with Potential Applications in Drug Development, Diagnosis, and/or Biotechnology
por: Hayashi, Mirian A. F., et al.
Publicado: (2012)

Marine Biotechnology
por: Qin, Song, et al.
Publicado: (2011)

Plant Biotechnology
por: Khawar, Khalid Mahmood, et al.
Publicado: (2013)

Pharmaceutical Biotechnology
por: Roque-Borda, Cesar Augusto, et al.
Publicado: (2022)

The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study
por: Spinillo, Arsenio, et al.
Publicado: (2016)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
por: Muñoz-Torrero, Diego, et al.
Publicado: (2017)

Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
por: Chabner, Bruce A.
Publicado: (2017)

Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches
por: Obi, Ogugua Ndili, et al.
Publicado: (2022)

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Alzheimer’s research—breakthrough or breakdown?
por: Spires-Jones, Tara L
Publicado: (2021)

Combating sepsis: bottlenecks to breakthroughs
Publicado: (2023)

Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis
por: Hedar, Ahmed M., et al.
Publicado: (2021)

COVID-19 breakthrough infections in rheumatic diseases patients after vaccination
por: Alshukairi, Abeer N., et al.
Publicado: (2022)

Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review
por: Triantafyllias, Konstantinos, et al.
Publicado: (2023)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–2
por: Muñoz-Torrero, Diego, et al.
Publicado: (2017)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3
por: Mangoni, Arduino A., et al.
Publicado: (2018)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–5
por: Mangoni, Arduino A., et al.
Publicado: (2019)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–4
por: Mangoni, Arduino A, et al.
Publicado: (2018)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7
por: Gütschow, Michael, et al.
Publicado: (2020)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–6
por: Vanden Eynde, Jean Jacques, et al.
Publicado: (2019)

Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases
por: Pizano-Martinez, Oscar, et al.
Publicado: (2023)

Biotechnology and Green Chemistry
por: Ribeiro, Bernardo Dias, et al.
Publicado: (2014)

Microbial Diversity for Biotechnology
por: Tsiamis, George, et al.
Publicado: (2014)

Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease
por: Cutolo, Maurizio
Publicado: (2008)

Welcome to Biotechnology for Biofuels
por: Hahn-Hägerdal, Bärbel, et al.
Publicado: (2008)

Will Biotechnology Overcrowd the Planet?
por: T. Avery, Dennis
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_67t69vh6l1uf329ad6etpe6id6